ESR1 and breast carcinoma: In this study, we investigated if 2′,3′,4′-trihydroxychalcone could be an alternative to progesterone and SERMs in MHT by reprogramming the effects of E2 on ERα-mediated gene regulation and breast cancer cell proliferation.